Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-24-001406
Filing Date
2024-10-15
Accepted
2024-10-15 12:12:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4480
  Complete submission text file 0001972362-24-001406.txt   6020
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Subject) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-50549 | Film No.: 241370844
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address
Yazji Salim (Reporting) CIK: 0001864486 (see all company filings)

Type: 144